Results 121 to 130 of about 7,743 (211)

Recent developments in treatments for eating disorders. [PDF]

Neurotherapeutics
Allam AR, Attia E.
europepmc   +1 more source

"Peeling paint" dermatosis in a leukemia patient. [PDF]

, 2020
Jerkins, James, Juhasz, Margit, Laquer, Vivian, Smith, Janellen   +3 more
core  

The role of the endocannabinoid system in managing neuropsychiatric symptoms in Alzheimer's disease. [PDF]

Front Psychiatry
Rao JS, Alejandra Tangarife M, Venegas MM, Forero B, González Tamayo LL, Escobar-Gallego JP, Rodríguez-Soacha DA, Ferreiros A, Mukunda R.   +8 more
europepmc   +1 more source

Computational Identification of Potent Multitarget Natural Ligands for Alzheimer's Disease Therapeutics. [PDF]

Scientifica (Cairo)
Sharif N, Bibi A, Sadiq R, Ullah I, Rauf A, Arshad MT, Bashir S, Zamir H, Gull S, Anwar T, Laryea E.   +10 more
europepmc   +1 more source

Cannabidiol and ∆9-Tetrahydrocannabinol in Endometriosis: A Literature Review on Therapeutic Applications and Mechanisms. [PDF]

JBRA Assist Reprod
Godoy JR, Castilhos JP, Caruso FB, Hentschke MR.   +3 more
europepmc   +1 more source

Relapszusprevenció drogfüggőknél [PDF]

, 2015
Rácz, József
core  

Exploring perceptions of cannabis use and employment implications among healthcare workers: a single-institution experience. [PDF]

J Cannabis Res
Lichtenberg AB, Mankabady RE, Mansour M, Wang A, Wagner C, Bay C, Bauer F.   +6 more
europepmc   +1 more source

A randomized dose finding study of combination dronabinol and acetazolamide for the treatment of obstructive sleep apnea. [PDF]

Sleep
Walsh J, Rankin T, Mehra S, Naughton MT, Roebuck T, McDermott E, Pattichis A, Smith R, Walsh R, Bleackley M, Maddison K, O'Brien TJ.   +11 more
europepmc   +1 more source

Randomized Laboratory Study of Single-Dose Cannabis, Dronabinol, and Placebo in Patients With Schizophrenia and Cannabis Use Disorder. [PDF]

Schizophr Bull
Brunette MF, Roth RM, Trask C, Khokhar JY, Ford JC, Park SH, Hickey SM, Zeffiro T, Xie H.   +8 more
europepmc   +1 more source

Effects of Voluntary Ingestion of Synthetic Delta-9-Tetrahydrocannabinol on the Hedonic Value of Rewarding and Aversive Substances and CB1 Receptor Expression. [PDF]

Cannabis Cannabinoid Res
Laux DA, Cain ME.
europepmc   +1 more source